Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Juan Moreno-Vedia"'
Autor:
Juan Moreno-Vedia, Dídac Llop, Ricardo Rodríguez-Calvo, Núria Plana, Núria Amigó, Roser Rosales, Yaiza Esteban, Josefa Girona, Lluís Masana, Daiana Ibarretxe
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background and aim Circulating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those diseases. Using proton nuclear magnetic resonance (1H-NMR), we aimed to study the plasma levels of low
Externí odkaz:
https://doaj.org/article/62ff23c29be742d58b465749722496e5
Autor:
Sara de Pablo, Júlia Rodríguez-Comas, Daniela Díaz-Catalán, Gema Alcarraz-Vizán, Carlos Castaño, Juan Moreno-Vedia, Joel Montane, Marcelina Parrizas, Joan-Marc Servitja, Anna Novials
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Amyloid deposits in pancreatic islets, mainly formed by human islet amyloid polypeptide (hIAPP) aggregation, have been associated with loss of β-cell mass and function, and are a pathological hallmark of type 2 diabetes (T2D). Treatment wit
Externí odkaz:
https://doaj.org/article/0369fa00d1f7444587242a36dc3bc794
Autor:
Juan Moreno-Vedia, Roser Rosales, Enrique Ozcariz, Dídac Llop, Maribel Lahuerta, María Benavent, Ricardo Rodríguez-Calvo, Núria Plana, Angels Pedragosa, Lluís Masana, Antoni Castro, Daiana Ibarretxe, Josefa Girona
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
High plasma triglyceride (TG) levels and chronic inflammation are important factors related to metabolic-associated fatty liver disease in patients at cardiovascular risk. Using nuclear magnetic resonance (1H-NMR), we aimed to study the triglyceride-
Externí odkaz:
https://doaj.org/article/f59f6e25cecd4c61b9821245106b0d3b
Autor:
Ricardo Rodríguez-Calvo, Juan Moreno-Vedia, Josefa Girona, Daiana Ibarretxe, Neus Martínez-Micaelo, Jordi Merino, Nuria Plana, Lluis Masana
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Background: Liver steatosis is considered the onset of the non-alcoholic fatty liver disease (NAFLD), a major public health challenge. Nevertheless, NAFLD detection and diagnosis remain a difficult task. Fatty acid binding protein 4 (FABP4) has been
Externí odkaz:
https://doaj.org/article/17837a7c8e7f40358dcf0681dfa31d95
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 197 (2022)
Metabolic-associated fatty liver disease (MAFLD), the main cause of chronic liver disease worldwide, is a progressive disease ranging from fatty liver to steatohepatitis (metabolic-associated steatohepatitis; MASH). Nevertheless, it remains underdiag
Externí odkaz:
https://doaj.org/article/47796b674941472a86c616d11ed0a1e0
Autor:
Júlia Rodríguez-Comas, Juan Moreno-Vedia, Mercè Obach, Carlos Castaño, Sara de Pablo, Gema Alcarraz-Vizán, Daniela Díaz-Catalán, Anna Mestre, Raquel Horrillo, Montserrat Costa, Anna Novials, Joan-Marc Servitja
Publikováno v:
Molecular Metabolism, Vol 37, Iss , Pp 100984- (2020)
Objective: Pancreatic β-cell failure is central to the development and progression of type 2 diabetes (T2D). The aggregation of human islet amyloid polypeptide (hIAPP) has been associated with pancreatic islet inflammation and dysfunction in T2D. Al
Externí odkaz:
https://doaj.org/article/a5c1a13a452440598ccd2dc0ac96e99b
Autor:
Natalia Andreychuk, Dídac Llop, Juan Moreno-Vedia, Josefa Girona, Daiana Ibarretxe, Cèlia Rodríguez-Borjabad, Núria Plana, Lluís Masana
Publikováno v:
Hypertension (Dallas, Tex. : 1979).
Background: Patients with hypertension present a permanent state of low-grade inflammation, as the disease activates several pro-inflammatory cells and inflammatory pathways. Glycoproteins A, B, and F, determined by proton nuclear magnetic resonance,
Autor:
Joan-Marc Servitja, Marcelina Párrizas, Carlos Castaño, Gema Alcarraz-Vizán, Daniela Díaz-Catalán, Joel Montane, Júlia Rodríguez-Comas, Anna Novials, Juan Moreno-Vedia, Sara de Pablo
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Amyloid deposits in pancreatic islets, mainly formed by human islet amyloid polypeptide (hIAPP) aggregation, have been associated with loss of β-cell mass and function, and are a pathological hallmark of type 2 diabetes (T2D). Treatment with chapero
Publikováno v:
Biomedicines
Biomedicines, Vol 10, Iss 197, p 197 (2022)
Biomedicines, Vol 10, Iss 197, p 197 (2022)
Metabolic-associated fatty liver disease (MAFLD), the main cause of chronic liver disease worldwide, is a progressive disease ranging from fatty liver to steatohepatitis (metabolic-associated steatohepatitis; MASH). Nevertheless, it remains underdiag
Autor:
Mercè Obach, Gema Alcarraz-Vizán, Júlia Rodríguez-Comas, Juan Moreno-Vedia, Anna Novials, Raquel Horrillo, Joan-Marc Servitja, Montserrat Costa, Carlos Castaño, Daniela Díaz-Catalán, Sara de Pablo, Anna Mestre
Publikováno v:
Molecular Metabolism, Vol 37, Iss, Pp 100984-(2020)
Molecular Metabolism
Molecular Metabolism
Objective Pancreatic β-cell failure is central to the development and progression of type 2 diabetes (T2D). The aggregation of human islet amyloid polypeptide (hIAPP) has been associated with pancreatic islet inflammation and dysfunction in T2D. Alp